FDA Issues Recall of 200 Vials of Sun Pharma’s Chemo Drug

by Kathy Jones on  July 4, 2014 at 10:35 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug manufactured by Indian pharma giant Sun Pharmaceuticals Industries.
 FDA Issues Recall of 200 Vials of Sun Pharma’s Chemo Drug
FDA Issues Recall of 200 Vials of Sun Pharma’s Chemo Drug

The drug in question is gemcitabine and the FDA revealed that it has recalled the vials as they have been manufactured at Sun Pharma's Caraco Pharmaceutical Laboratories Ltd. plant in Gujarat, which the health regulator claimed does not abide by its sterility standards and hence the vials' safety cannot be assured.

This is the third time that Sun Pharma has fallen foul of the FDA this year with the health regulator issuing an import ban on the company's Karkhadi plant in Gujarat after finding it not up to the standards while Sun Pharma had issued a voluntary recall of over 2,500 bottles of Glumetza back in January.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive